Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
Enrique J. Arenas(Vall d'Hebron Institut de Recerca), Joaquı́n Arribas(Institució Catalana de Recerca i Estudis Avançats)
Cited by 56
Related Papers
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer
|Cancer Research|2022|41
Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence
|Breast Cancer Research|2015|13